Stockwhore

1 Comment

    • Genentech Stock Slide: FDA Meeting Should Have Been Webcast [view article]
      I couldn't agree more. It was clear from Genentech's 4:45pm conference call with analysts, that some were present in the room at the advisory committee meeting in Gaithersburg, MD. This is a clear example of certain parts of the market having unfair access to information affecting stock price. The FDA can and should webcast the meetings. To paraphrase Susan Desomond-Heller, Executive VP for Product and Development at Genentech, the feelings of many of the advisory committee members were very clear even before they voted. Dec 06 11:48 AM
Contribute an Article Become a Seeking Alpha Contributor